Resolution on Appointment of Madlyn K. Abramson to the Penn Medicine Executive Committee

Intention:

Section 7 .4 of the Statutes of the University of Pennsylvania and Section 4.1 of the Bylaws o f Penn Medicine provide for the appointment of members of the Penn Medicine Executiv e Committee upon nomination by the Chairman of the Board of Trustees of the University, th e Chairman of the Penn Medicine Board, and the President of the University, acting jointly , and approval by the University Trustees . Section 4.1 further states that the Penn Medicine Executive Committee shall consist of no more than 16 members, a majority of whom (no t including the EVP/Dean, the Vice President for Finance and Treasurer, and the CEO) shal l be University Trustees . The appointed members of the Penn Medicine Executive Committee serve at the pleasure of the Chairman of the Board of Trustees of the University, th e Chairman of the Penn Medicine Board, and the President of the University .

ACCORDINGLY, IT IS HEREBY

RESOLVED, that Madlyn K. Abramson, a University trustee, be appointed to the Penn Medicine Executive Committee, effective September 26, 2002, to serve in accordance wit h the Bylaws of Penn Medicine .

47 Resolution on Appointment of Jerome H . Grossman, M.D., to the Penn Medicine Board

Intention:

Section 7.4 of the Statutes of the University of Pennsylvania and Section 3 of the Bylaws o f Penn Medicine provide for the appointment of members of the Penn Medicine Board, upo n nomination by the Chairman of the Board of Trustees of the University, the Chairman of the Penn Medicine Board, and the President of the University, acting jointly. The members shal l be persons who, by their experience and expertise can further the mission of Penn Medicine . Pursuant to Section 3 .3 of the Bylaws of Penn Medicine each member of the Board othe r than ex-officio members shall hold office for a term of three (3) years, or until his or her successor is elected and qualified, unless he or she sooner dies, resigns, is removed, o r becomes disqualified.

Jerome H. Grossman, M.D., M'65, is a nationally recognized expert on and proponent o f health services research as a means of improving health . He currently serves as a Senior Fellow at the Center for Business and Government and Director of the Project on Healthcar e Delivery at Harvard's John F. Kennedy School of Government . Prior to his arrival at the Kennedy School in 2001, Dr. Grossman was President and CEO of Lion Gate Management Corp., a holding company focused on health-care quality and delivery issues .

Dr. Grossman is Chairman Emeritus of New England Medical Center, where he served as Chairman and CEO from 1979 to 1995 . He is also an honorary physician at Massachusetts General Hospital, where he practiced full time from 1966 to 1979 . Dr. Grossman was a member of the founding team of several health-care companies, including Meditech, a medical software company, as well as Tufts Associated Health Plan, Chartwell Home Therapies, and Transition Systems, Inc. He was named to the Institute of Medicine of the National Academy of the Sciences in 1983 and served as scholar in residence at the Institut e in 1996 . He also served on the Board of the Federal Reserve Bank of from 1990 to 1997 and was its chairman from 1994 to 1997 . Dr. Grossman completed his undergraduat e work at MIT in 1961 and earned his medical degree from Penn in 1965 . He was awarded th e School of Medicine's Distinguished Graduate Award in 1997 .

ACCORDINGLY, IT IS HEREB Y

RESOLVED, that Jerome H. Grossman, M.D., be appointed to the Penn Medicine Board , effective September 26, 2002, to serve in accordance with the Bylaws of Penn Medicine .

48 Resolution on Appointment of Jeffrey Leiden, M .D., Ph.D., to the Penn Medicine Board

Intention:

Section 7.4 of the Statutes of the University of Pennsylvania and Section 3 of the Bylaws o f Penn Medicine provide for the appointment of members of the Penn Medicine Board, upon nomination by the Chairman of the Board of Trustees of the University, the Chairman of th e Penn Medicine Board, and the President of the University, acting jointly. The members shall be persons who, by their experience and expertise can further the mission of Penn Medicine . Pursuant to Section 3 .3 of the Bylaws of Penn Medicine each member of the Board othe r than ex-officio members shall hold office for a term of three (3) years, or until his or he r successor is elected and qualified, unless he or she sooner dies, resigns, is removed, o r becomes disqualified.

Jeffrey Leiden, M.D., Ph.D ., President and Chief Operating Officer of ' Pharmaceutical Products Group since December 2001, also serves as Abbott's Chie f Scientific Officer and is a member of Abbott's Board of Directors. Prior to joining Abbott, Dr. Leiden served as the Elkan R . Blout Professor of Biological Sciences, Harvard School o f Public Health, and Professor of Medicine, Harvard Medical School . Prior to that, he was the Frederick H. Rawson Professor of Medicine and Pathology and Chief of the Section o f Cardiology at the University of .

Dr. Leiden's extensive business and consulting experience includes both the pharmaceutica l and medical device arenas. He was a founder of Cardiogene, Inc., a biotechnology company specializing in cardiovascular gene therapy .

Dr. Leiden currently serves on the board of directors of TAP Pharmaceutical Products, Inc ., the Ravinia Festival, the Keystone Symposia, and the Museum of Science and Industry . He is president of the Molecular Medicine Society, and is a member of the American Society fo r Clinical Investigation, the American Association of Physicians, and the American Academ y of Arts and Sciences. He was elected to the Institute of Medicine of the National Academy of Sciences in 2001 . Dr. Leiden earned a bachelor's degree in biological sciences, a doctorat e in virology, and a medical degree, all from the .

ACCORDINGLY, IT IS HEREB Y

RESOLVED, that Jeffrey Leiden, M.D., Ph.D., be appointed to the Penn Medicine Board , effective September 26, 2002, to serve in accordance with the Bylaws of Penn Medicine.

49 Resolution on Appointment of Rosemary Mazanet, M .D., Ph.D. to the Penn Medicine Board

Intention:

Section 7.4 of the Statutes of the University of Pennsylvania and Section 3 of the Bylaws o f Penn Medicine provide for the appointment of members of the Penn Medicine Board, upo n nomination by the Chairman of the Board of Trustees of the University, the Chairman of the Penn Medicine Board, and the President of the University, acting jointly. The members shal l be persons who, by their experience and expertise can further the mission of Penn Medicine . Pursuant to Section 3 .3 of the Bylaws of Penn Medicine each member of the Board othe r than ex-officio members shall hold office for a term of three (3) years, or until his or he r successor is elected and qualified, unless he or she sooner dies, resigns, is removed, or becomes disqualified.

Rosemary Mazanet, M .D., GR'81, M'86, joined Oracle Investment Management, a private equity and hedge-fund company focused on the healthcare industry, in 1997 . As Chief Scientific Officer and Director of Research, Dr . Mazanet directs the scientific and medical evaluation of Oracle's investments . She also identifies unique private investment opportunities and directs the due diligence and ongoing analysis associated with Oracle' s existing and potential investments .

Prior to joining Oracle, Dr . Mazanet served as the Director of Clinical Research at Amgen . Prior to that, she was an Attending Physician at the Dana Farber Cancer Institute an d Brigham and Women's Hospital in Boston, as well as an instructor at Harvard Medica l School. Dr. Mazanet currently holds a faculty appointment at Columbia-Presbyterian Medical Center in New York. A graduate of the University of Virginia, Dr . Mazanet received her Ph.D. from Penn's Department of Anatomy and Cell Biology in 1981 and he r medical degree from Penn in 1986 .

ACCORDINGLY, IT IS HEREB Y

RESOLVED, that Rosemary Mazanet, M .D., be appointed to the Penn Medicine Board, effective September 26, 2002, to serve in accordance with the Bylaws of Penn Medicine .

50 Resolution on Appointment of Eve Lloyd Thompso n to the Board of Overseers of the School of Veterinary Medicin e

RESOLVED, that Eve Lloyd Thompson be appointed to the Board of Overseers of the School of Veterinary Medicine for a three-year term, effective September 26 , 2002.

Eve Lloyd Thompson is the Trustee, Treasurer and Secretary of the Bernice Barbou r Foundation, a private foundation dedicated to the prevention of cruelty to animal s and to their well being, protection and care .

Ms. Thompson has been a horse owner, breeder, and hands-on caretaker for more than thirty years. She has bred and owned thoroughbred flat and jump race winner s and Arabian halter and performance champions, as well as champion show hunter s and jumpers . She currently competes in the dressage division .

Ms . Thompson is a member of the Deans Advisory Council at the University o f California at Davis School of Veterinary Medicine . She has also served as a consultant to the Sport Committee of the former Soviet Union and HTS (Fox) T V cable in Washington, DC, on issues related to equine sports. Her areas of expertis e include equine ancestry, physical and behavioral characteristics, traits, and performance. She received her bachelor of arts degree in Zoology from Cornel l University, and has done graduate work in animal nutrition at the University of Maryland .

51 Resolution on Reappointment of Lawrence J . Schoenberg as Chair of the Board of Overseers of the University Libraries

RESOLVED, that Lawrence J. Schoenberg be reappointed as Chair of the Board of Overseers of the University Libraries for a three-year term, effective September 26 , 2002 .

Lawrence J. Schoenberg (C53, WG56) is founder and former Chief Executive Office r of AGS Computers, Inc. He holds directorships in numerous corporations in the micro-computing and software development industry, including Merisel, Inc .; Government Technology Services, Inc .; SunGuard Data Services, Inc .; Image Business Systems, Inc.; Penn American Group, Inc .; Soft-Switch, Inc.; Q-Star, Inc .; and Forecross Corporation . He sits on the boards of the American Business Conference, the Charles Babbage Institute, Dickinson College and the Informatio n Technologies Association of America (formerly ADAPSO) .

At Penn, Mr. Schoenberg has been a member of the Board of Overseers of th e University Libraries since 1994 and has served as its Chair since 1999 .

52 Resolution on Reappointment of Richard A . Collier, Esq., as Chair of the Board of Overseers of the School of Dental Medicine

RESOLVED, that Richard A. Collier, Esq., be reappointed as Chair of the Board of Overseers of the School of Dental Medicine for a three-year term, effective September 26, 2002.

Richard A . Collier, Esq ., (W66, WG67) is President of Collier, Sarner an d Associates, Inc ., a national law firm, which specializes in medical practices . He is editor and publisher of the bi-monthly publication, Collier, Sarner and Associates Doctors' Newsletter, which provides information on taxes, insurance, investments , and practice transition to thousands of doctors nationwide . Mr. Collier lectures extensively on these pertinent topics as a featured clinician at national, regional , state and local meetings . He holds a law degree from the .

At Penn, Mr. Collier has been a member of the Board of Overseers of the School of Dental Medicine since 1995 and has served as Chair of the Board since 1999 .

53 Resolution on Reappointment of John C . Hover II as Chair of the Board of Overseers of th e University Museum of Archaeology and Anthropolog y

RESOLVED, that John C. Hover II be reappointed as Chair of the Board o f Overseers of the University Museum of Archaeology and Anthropology for a three - year term, effective September 26, 2002 .

John C. Hover II (C65, WG67) retired in January 1999 from the United States Trus t Company of New York where he served in various positions for more than 22 years , most recently as Executive Vice President in Charge of Personal Asset Managemen t and Private Banking and Chairman of US Trust International . Mr. Hover continues as Chairman of the Board of US Trusts private equity funds .

At Penn, Mr . Hover has served as a University Trustee since 1996 and as Chair of th e University Museum Board of Overseers since 1999 . He was a Governor and President of the former Penn Club in New York and was co-Chair of the committe e that raised funds for the present Penn Club of New York, of which he is Vic e President. He has also served for more than 20 years as a member of Penns Alumn i Secondary School Committee .

54 Resolution on Reappointment of the Honorary Marjorie O . Rendell as Chair of the Board of Overseers of the School of Nursin g

RESOLVED, that the Honorable Marjorie O . Rendell be reappointed as Chai r of the Board of Overseers of the School of Nursing for a three-year term, effectiv e September 26, 2002 .

The Honorable Marjorie O . Rendell (CW69) was inducted as a judge of the United States Court of Appeals for the Third Circuit in 1997 . Prior to her current appointment, she served as a judge of the United States District Court for th e Eastern District of Pennsylvania . Judge Rendell is a member of the Federal Judges Association, the American Judicature Society, and the National Association o f Women Judges . She also serves as the co-Chair of Avenue of the Arts, Inc ., and Vice Chair of the Regional Performing Arts Center.

At Penn, Judge Rendell has served as a trustee since 1995 and as Chair of the Boar d of Overseers of the School of Nursing since 1999 . She is a member of the Trustees Council of Penn Women and the Athletic Advisory Board . She additionally serves as Chair of the Penn Alumni Society Nominations Committee .

55 Resolution on Reappointment of the Jon M. Huntsman, Sr., as Chair of the Board of Overseers of the Wharton Schoo l

RESOLVED, that Jon M . Huntsman, Sr., be reappointed as Chair of the Boar d of Overseers of the Wharton School for a three-year term, effective September 26, 2002.

Jon M . Huntsman, Sr. (W'59, HON'96) is Chairman and CEO of Huntsman Chemica l Corporation, which is the largest privately held chemical business in the Unite d States. He serves on numerous corporate, civic and cultural boards, including th e Board of Governors of the American Red Cross, and is co-Chair of the Nationa l Prostate Cancer Coalition . He is a former member of the Board of Directors of Bankers Trust of New York, a former Vice-Chairman of the Board of the Unite d States Chamber of Commerce, and former Chairman of the Board of the Uta h Symphony Orchestra.

At Penn, Mr. Huntsman served as a University Trustee from 1987 to 1992, and i s currently serving a second term, which began in 2001 . He has served as Chair of th e Board of Overseers of the Wharton School since 1999 and is currently a member o f the Steering Committee of the Wharton Campaign for Sustained Leadership . Mr. Huntsman is former co-Chair of the Campaign for Penn and former Chair of th e Advisory Board for the Huntsman Center for Global Competition and Leadership .

56